FDA Cites Pfizer Zyrtec-D Promotions For Omission Of Risk Information
This article was originally published in The Pink Sheet Daily
Executive Summary
A professional sales aid and the product website fail to include contraindications and warnings for the drug’s decongestant component pseudoephedrine, an FDA ad division letter states.